Renal toxicity of long-term ciclosporin

Scandinavian Journal of Rheumatology

Volumn 28, Issue 2, 1999, Pages 65-68

  Zachariae, Hugh ^a  

^a Ildervej 40   (Denmark)

Author keywords

Auto immune dieseases; Ciclosporin; Long term treatment; Renal toxicity

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOSPORIN A; NONSTEROID ANTIINFLAMMATORY AGENT;

AUTOIMMUNE DISEASE; CLINICAL ARTICLE; DOSE RESPONSE; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; KIDNEY BIOPSY; KIDNEY FIBROSIS; LONG TERM CARE; NEPHROTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0032962258     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097499442504     Document Type: Review

References (32)

1. 1. Brown M, Ellis C, Voorhees J. Cyclosporin A: A review of its dermatologic applications. Semin Dermatol 1987;6:2-9.
2. 2. Van Rijthoven A, Dijkmans B, Goci Thè H, Hermans J, Montnor-Beckers Z, Jacobs P, et al. Cyclosporin treatment of rheumatoid arthritis: A placebo controlled, double-blind, multicentre study. Ann Rheum Dis 1986;45:726-31.
3. 3. Zachariae II, Halkier-Søorensen L, Heikendorff L, Zachariae E, Hansen HE. Cyclosporin A treatment of systemic sclerosis. Br J Dermatol 1990;122:677-81.
4. 4. Brynskov J, Freund L, Rasmussen S, Lauritsen K, Schaffalitzky de Muckadell, Williams N, et al. A placebo-controlled trial of cyclosporine therapy in active Chron's disease. N Engl J Med 1989;321:845-50.
5. 5. Rhadakrishnan J, Kunis C, d'Agati V, Appel G. Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 1994;42:147-54.
6. 6. Menter A, Cyclosporine. Semin Dermatol 1992;11 Suppl. 1: 30-4.
7. 7. Mihatsch M, Thiel G, Ryffel B. Histopathology of cyclosporin nephrotoxicity. Transplant Proc 1988;20 Suppl. 3:759-71.
8. 8. Ruiz P, Kolbeck P, Scroggs M, Sanflippo F. Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation 1988;45:91-5.
9. 9. Fioretto P, Steffes M, Mihatsch M, Strom E, Sutherland D, Mauer M. Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant patients. Kidney Int 1995;48:489-95.
10. 10. Mihatsch M, Wolff K. Consensus conference on cyclosporin A for psoriasis, February 1992. Br J Dermatol 1992;126:621-3.
11. 11. Panayi G, Tugwell P. The use of cyclosporin A in rheumatoid arthritis: Conclusions of an international review. Br J Rheumatol 1994:33:997-9.
12. 12. Zachariae H, Kragballe K, Hansen HE, Marcussen N, Olsen S. Renal biopsy findings in long-term cyclosporin treatment of psoriasis. Br J Dermatol 1997;136:531-5.
13. 13. Vercauteren S, Bosmans J-L, Elseviers M, Verpooten G, de Broe M. A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseases. Kidney Int 1998;54:536-45.
14. 14. Altman R, Periz G, Sfakianakis G. Interaction of cyclosporine A and non-steroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis. Am J Med 1992;93: 396-402.
15. 15. De Broc M, Stolear J, Nouwen E, Elseviers M. 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstial nephritis in patients with chronic inflammatory bowel disease: Is there a link? Nephrol Dial Transplant 1997;12:1839-41.
16. 16. Zachariae H, Kragballe K, Hansen HF, Marcussen N, Olsen S. Renal biopsies in relation to long-term treatment of psoriasis. Ugeskr Læger 1998;160:4534-8.
17. 17. Leaker B, Cairns H. Clinical aspects of cyclosporin nephrotoxicity. Br J Hosp Med 1994;52:529-34.
18. 18. Madsen J, Zachariae H, Pedersen E. Effects of the calcium antagonist felodipine on renal haemodynamics, tubular sodium handling, and blood pressure in cyclosporin-treated dermatological patients. Nephrol Dial Transplant 1997; 12:480-4.
19. 19. Mihatsch M, Antonovych T, Bohman S, Habib R, Helmchen U, Noel L, Olsen S, Sibley R, Kemény G, Feutren G. Cyclosporine A nephropathy: standardization of the evaluation of kidney biopsies. Clin Nephrol 1994;41:23-32.
20. 20. Landewé R, Dijkmans B, van den Woude F, Breedveld F, Mihatsch M, Bruijn J. Long-term low dose cyclosporine in patients with rheumatoid arthritis: Renal function loss without structural nephropathy. J Rheumatol 1996;23:61-4.
21. 21. Sund S, Førre O, Berg K, Kvien T, Hovig T. Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis. Clin Nephrol 1994;41:33-40.
22. 22. Svarstad E, Helland S, Morken T, Bostad L, Myking A, Iversen B, et al. Renal effects of maintenance low-dose cyclosporin A treatment in psoriasis. Nephrol Dial Transplant 1994;9: 1462-7.
23. 23. Zachariae H, Hansen HE, Kragballe K, Olsen S. Morphologic renal changes during cyclosporine treatment of psoriasis. J Am Acad Dermatol 1992;26:415-9.
24. 24. Zachariae H, Hansen HF, Olsen S. Hemolytic uremic syndrome in a patient with systemic sclerosis treated with cyclosporin A. Acta Derm Venereol (Stockh) 1992;72:307-9.
25. 25. Denton C, Sweny P, Abdulla A, Black C. Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases. Br J Rheumatol 1994;33:90-2.
26. 26. Ruiz J, Val F, de Fransisco A, de Bonis E, Zubimendi J, Prieto M, et al. Progressive systemic sclerosis and renal transplantation: a contraindication to ciclosporin. Nephron 1991;59: 330-2.
27. 27. Myers B, Newton L. Cyclosporin induced chronic nephropathy: An obliterative microvascular renal injury. J Am Soc Nephrol 1991;2 Supp. 1:545-52.
28. 28. Myers B, Sibley R, Newton L, Tomlanovich S, Boshker C, Stinson E, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988;33:590-600.
29. 29. Ben Hmida M, Baumelou A, Desruesnnes M, Cabrol A, Pavic A, Grandjbakhch I Cabrol C. Long-term nephrotoxicity of low doses of cyclosporine in heart transplant recipients. Transplant Proc 1995;5:2725-7.
30. 30. Kovarik J, Mueller E, van Bree J, Tetzloff W, Kutz K, Reduced inter-and intra-individual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 1994;83:444.
31. 31. Lim K, Su W, Schroeter A, Sabers C, Abraham R, Pittelkow M. Cyclosporine in the treatment of dermatologic diseases: an update.
32. 32. Kruger K. Use of cyclosporin A in chronic polyarthritis and other rheumatic diseases. Z Rheumatol 1995;54:89-95.